PROTEONOMIX
Our Technologies were developed over years of research and development at leading US medical universities. Several technologies are entering the commercialization phase and others are ready to proceed through the FDA phased human trials process.
PROTEONOMIX
Industry:
Biotechnology Diabetes Health Care
Founded:
1995-01-01
Address:
Hawthorne, New Jersey, United States
Country:
United States
Website Url:
http://www.proteonomix.com
Total Employee:
1+
Status:
Active
Contact:
973.544.6116
Email Addresses:
[email protected]
Total Funding:
3.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF GoDaddy DNS Google Google Cloud OpenResty Google Adsense GoDaddy Email Google Cloud Global Multi-Region
Similar Organizations
Avobis Bio
Avobis Bio develops investigational implantable cell therapies to treat debilitating conditions.
Current Employees Featured
Founder
Official Site Inspections
http://www.proteonomix.com
- Host name: ec2-44-230-85-241.us-west-2.compute.amazonaws.com
- IP address: 44.230.85.241
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "proteonomix"
Proteonomix, Inc. (PROT) Company Profile & Facts - Yahoo Finance
See the company profile for Proteonomix, Inc. (PROT) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Proteonomix Company Profile 2024: Stock Performance
Proteonomix General Information Description. Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company …See details»
proteonomix - Contacts, Employees, Board Members, Advisors
Organization. proteonomix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. proteonomix has …See details»
Proteonomix - Products, Competitors, Financials, Employees ...
Proteonomix is a biotechnology company that focuses on developing therapeutics based on the use of non-embryonic human stem cells and their derivatives. Use the CB Insights Platform to …See details»
Proteonomix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Proteonomix, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 5 news, Drug:Autologous stem cell therapy (Proteonomix).See details»
EIN 13-3842844 - Proteonomix, Inc., Mountainside, New Jersey
The Employer Identification Number (EIN) for Proteonomix, Inc. is 13-3842844. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Proteonomix, Inc.. Toggle …See details»
proteonomix - Funding, Financials, Valuation & Investors
Proteonomix develops therapies using human stem cells and their derivatives to treat diabetes and cardiac diseases.See details»
Proteonomix, Inc. Company Profile & Data: stocks, market cap ...
Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey. Top 1-year algo backtest: +327.04% $10,000 in March 2024 would now be $42,704 by following this …See details»
Proteonomix - 2025 Company Profile, Funding & Competitors
Feb 25, 2025 Proteonomix - Developing therapeutics based upon the use of human stem cells and their derivatives to treat cardiac diseases.. This company is not active anymore. Raised a …See details»
PROT | Proteonomix Inc. Profile - MarketWatch
Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre-clinical stage therapeutic …See details»
Proteonomix, Inc. (PROT)
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti …See details»
Organization | Proteonomix, Inc.
Proteonomix, Inc. Report issue. For profit Phase 2. Founded: Hawthorne NJ United States ... Organization Overview. First Clinical Trial. 2012 NCT01711073. First Marketed Drug. None …See details»
Company PROTEONOMIX - MarketScreener.com
Stromacel Inc. is a biotechnology company. The Company is a subsidiary of Proteonomix Inc. It offers technology in the field of cellular medicine to international clients. The Company intends …See details»
Proteonomix (PROT) Stock Price, News & Analysis - MarketBeat
Mar 22, 2025 Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include …See details»
Autologous stem cell therapy (Proteonomix) - Drug Targets
PARAMUS, N.J., Jan. 14, 2013 /PRNewswire/ -- Proteonomix, Inc. (the "Company") (SYMBOL: PROT), a biotechnology company (the "Company") focused on developing therapeutics based …See details»
proteonomix - Tech Stack, Apps, Patents & Trademarks
Proteonomix develops therapies using human stem cells and their derivatives to treat diabetes and cardiac diseases.See details»
Autologous stem cell therapy - Proteonomix - AdisInsight - Springer
Proteonomix and its subsidiaries are developing an autologous stem cell therapy based on their proprietary stem cell mobilisation technology UMK 121, for tissueSee details»
Deep Visual Proteomics maps proteotoxicity in a genetic liver
2 days ago a, Overview of the Deep Visual Proteomics workflow.Fibrosis stages are Kleiner scores. b, Immunofluorescence staining of AAT, the cell outline marker pan-cadherin (pan …See details»
proteonomix - Crunchbase
Proteonomix develops therapies using human stem cells and their derivatives to treat diabetes and cardiac diseases.See details»